Browsing by Author rp00501

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 中
Showing results 1 to 20 of 71  next >
TitleAuthor(s)Issue Date
 
Acute presentation of rheumatoid arthritis following cancer chemotherapy using the topoisomerase I inhibitor irinotecan [3]
Journal:Acta Oncologica
Yau, TCChu, KWMok, MYLiang, RHEpstein, RJ
2005
 
Adaptive evolution hotspots at the GC-extremes of the human genome: Evidence for two functionally distinct pathways of positive selection
Journal:Advances in Bioinformatics
Epstein, Richard J.Tang, Clara S M
2010
 
Adjuvant breast cancer chemotherapy during late-trimester pregnancy: Not quite a standard of care
Journal:BMC Cancer
Epstein, RJ
2007
 
Bevacizumab-based therapy for advanced small bowel adenocarcinoma
Journal:Gut
Tsang, HYau, TKhong, PLEpstein, RJ
2008
 
Breast self examination. Breast self examination provides entry strategy.
Journal:BMJ (Clinical research ed.)
Epstein, RJ
2003
 
Cancer prevention: are we nearly there?
Proceeding/Conference:Hong Kong Medical Forum, HKMF 2003
Epstein, R
2003
 
A case of mixed adult Wilms' tumour and angiosarcoma responsive to carboplatin, etoposide and vincristine (CEO)
Journal:Cancer Chemotherapy and Pharmacology
Yau, TLeong, CHChan, WKChan, JKLiang, RHSEpstein, RJ
2008
 
Clinicopathologic correlates in a cohort of Hong Kong breast cancer patients presenting with screen-detected or symptomatic disease
Journal:Hong Kong Medical Journal
Leung, AWMak, JCheung, PSYEpstein, R
2007
 
Coexisting ductal carcinoma in situ independently predicts lower tumor aggressiveness in node-positive luminal breast cancer
Journal:Medical Oncology
Wong, HLau, SLeung, RChiu, JCheung, PWong, TTLiang, REpstein, RJYau, T
2012
 
Complications of traditional Chinese/herbal medicines (TCM)-a guide for perplexed oncologists and other cancer caregivers
Journal:Supportive Care in Cancer
Chiu, JYau, TEpstein, RJ
2009
 
Costs and benefits of dose-dense chemotherapy scheduling in Hong Kong Chinese patients with primary breast cancer
Proceeding/Conference:ASCO Annual Meeting Proceedings
Tsang, JYau, TChan, ATCLiang, RHSYeo, WEpstein, R
2007
 
Current issues: multidisciplinary management of breast cancer
Journal:Business Brief
Cheung, PSYEpstein, R
2004
 
The CXCL12-CXCR4 chemotactic pathway as a target of adjuvant breast cancer therapies
Journal:Nature Reviews Cancer
Epstein, RJ
2004
 
A double-blind, placebo-controlled, randomized trial of oral sodium clodronate for metastatic prostate cancer
Journal:Journal of National Cancer Institute
Dearnaley, DPEpstein, R
2003
 
Efficacy and tolerability of adjuvant oral capecitabine plus intravenous oxaliplatin (XELOX) in Asian patients with colorectal cancer: 4-year analysis
Journal:Asian Pacific Journal of Cancer Prevention
Chiu, JoanneTang, VikkiLeung, RolandWong, HildaChu, KinwahPoon, JensenEpstein, Richard JohnYau, Thomas
2013
 
Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma
Proceeding/Conference:Oncology
Yau, TChan, PWong, HNg, KKChok, KSHCheung, TTLam, VEpstein, RJFan, STPoon, RTP
2007
 
Evolution of systemic therapy of advanced hepatocellular carcinoma
Journal:World Journal of Gastroenterology
Yau, TChan, PEpstein, RPoon, RT
2008
 
Evolutionary conservation of hypermutable codons within human genes
Proceeding/Conference:Hong Kong Medical Genetics Conference
Zhao, YTang, SMEpstein, R
2005
 
Future adjuvant use of molecularly-targeted (smart) drugs for liver cancer: prospects and problems.
Journal:Proc Clin Trials Workshops
Epstein, R
2004
 
Growth inhibition of human cancer cells by 5-aza-2'-deoxycytidine does not correlate with its effects on INK4a/ARF expression or initial promoter methylation status.
Journal:Molecular Cancer Therapeutics
Xiong, JEpstein, R
2009
Showing results 1 to 20 of 71  next >